Cardiac molecular imaging stands at the forefront of cardiovascular research, employing state-of-the-art imaging methodologies to unravel the intricate molecular dynamics within the heart. This innovative field enables a comprehensive exploration of the cellular and molecular intricacies that dictate cardiac function and health. Through the application of specialized imaging agents, scientists can pinpoint and study specific molecular indicators linked to various cardiovascular conditions. The precision offered by cardiac molecular imaging holds the potential for transformative advancements in early disease detection, accurate diagnosis, and the development of personalized therapeutic approaches. This evolving discipline is poised to redefine our understanding of cardiovascular health by shedding light on the nuanced molecular pathways, opening avenues for more targeted interventions and improved patient care.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : CARDIAC TROPONIN AND HOMOCYSTEINE LEVELS IN HEMODIALYSIS PATIENTS: ASSOCIATION WITH DIALYSIS VINTAGE AND CARDIOVASCULAR COMORBIDITY
Sofra Maria, Aretaieion University Hospital, Greece
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation